APONTIS PHARMA AG (APPH.DE) Stock Price, Quote, News and Overview
FRA:APPH - Deutsche Boerse Ag - DE000A3CMGM5 - Common Stock - Currency: EUR
APPH.DE Quote, Performance and Key Statistics
FRA:APPH (6/2/2025, 7:00:00 PM)
11.6
0 (0%)
The current stock price of APPH.DE is 11.6 EUR. In the past month the price increased by 3.57%. In the past year, price increased by 36.15%.
APPH.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 54.95 | 627.59B | ||
| 1LLY.MI | ELI LILLY & CO | 53.88 | 615.27B | ||
| ZEG.DE | ASTRAZENECA PLC | 16.42 | 389.56B | ||
| JNJ.DE | JOHNSON & JOHNSON | 15.46 | 327.27B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 15.32 | 324.34B | ||
| NOV.DE | NOVO NORDISK A/S-B | 19.87 | 278.07B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.94 | 243.42B | ||
| SAN.PA | SANOFI | 11.28 | 211.17B | ||
| SNW.DE | SANOFI | 11.17 | 209.08B | ||
| NOT.DE | NOVARTIS AG-REG | 13.97 | 200.35B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 13.64 | 195.53B | ||
| 1MRKX.MI | MERCK & CO. INC. | 10.03 | 171.75B |
Related stock screener links
About APPH.DE
Company Profile
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 137 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Company Info
APONTIS PHARMA AG
Rolf-Schwarz-Schuette-Platz 1
Monheim Am Rhein NORDRHEIN-WESTFALEN DE
Employees: 177
APONTIS PHARMA AG / APPH.DE FAQ
What is the stock price of APONTIS PHARMA AG today?
The current stock price of APPH.DE is 11.6 EUR.
What is the ticker symbol for APONTIS PHARMA AG stock?
The exchange symbol of APONTIS PHARMA AG is APPH and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is APPH.DE stock listed?
APPH.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for APONTIS PHARMA AG stock?
12 analysts have analysed APPH.DE and the average price target is 13.77 EUR. This implies a price increase of 18.71% is expected in the next year compared to the current price of 11.6. Check the APONTIS PHARMA AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APONTIS PHARMA AG worth?
APONTIS PHARMA AG (APPH.DE) has a market capitalization of 98.60M EUR. This makes APPH.DE a Micro Cap stock.
How many employees does APONTIS PHARMA AG have?
APONTIS PHARMA AG (APPH.DE) currently has 177 employees.
What are the support and resistance levels for APONTIS PHARMA AG (APPH.DE) stock?
APONTIS PHARMA AG (APPH.DE) has a support level at 11.48 and a resistance level at 11.6. Check the full technical report for a detailed analysis of APPH.DE support and resistance levels.
Is APONTIS PHARMA AG (APPH.DE) expected to grow?
The Revenue of APONTIS PHARMA AG (APPH.DE) is expected to grow by 15.94% in the next year. Check the estimates tab for more information on the APPH.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APONTIS PHARMA AG (APPH.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APPH.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APPH.DE, evaluating the profitability, health, valuation and growth aspects
- APONTIS PHARMA AG (APPH.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APONTIS PHARMA AG (APPH.DE) Sales and EPS estimates to see what analysts future expectations are.
- APONTIS PHARMA AG (APPH.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APONTIS PHARMA AG (APPH.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- APONTIS PHARMA AG (APPH.DE) Stock Chart to make your own analysis
- APONTIS PHARMA AG (APPH.DE) Latest news and press-releases to stay up to date.
Does APONTIS PHARMA AG (APPH.DE) stock pay dividends?
APPH.DE does not pay a dividend.
What is the Price/Earnings (PE) ratio of APONTIS PHARMA AG (APPH.DE)?
The PE ratio for APONTIS PHARMA AG (APPH.DE) is 77.33. This is based on the reported non-GAAP earnings per share of 0.15 and the current share price of 11.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for APPH.DE.
APPH.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to APPH.DE. When comparing the yearly performance of all stocks, APPH.DE is one of the better performing stocks in the market, outperforming 89.67% of all stocks.
APPH.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to APPH.DE. No worries on liquidiy or solvency for APPH.DE as it has an excellent financial health rating, but there are worries on the profitability.
APPH.DE Financial Highlights
Over the last trailing twelve months APPH.DE reported a non-GAAP Earnings per Share(EPS) of 0.15. The EPS increased by 106.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.75% | ||
| ROA | 2.82% | ||
| ROE | 4.03% | ||
| Debt/Equity | 0 |
APPH.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to APPH.DE. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 290.99% and a revenue growth 15.94% for APPH.DE